DPP4 and type 2 diabetes mellitus: Treatment with antiglycemic agents in patients with various chronic liver diseases has been well studied, but there are relatively few related studies on dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), especially in patients with coexisting T2DM and chronic HBV infection.